Evidence map›Paper›PMID 31776863›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2020

Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.

Fabio Brito-Santos, Maria Helena Galdino Figueiredo-Carvalho, Rowena Alves Coelho, Jean Carlos Almeida de Oliveira, Raissa Vieira Monteiro, Alessandra Leal da Silva Chaves, Rodrigo Almeida-Paes

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. A Repertoire of the Less Common Clinical Yeasts.Journal of fungi (Basel, Switzerland) · 2023
    Review
  2. Rare Yeasts in Latin America: Uncommon Yet Meaningful.Journal of fungi (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fabio Brito-SantosMycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, FIOCRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil. fabio.santos@ini.fiocruz.br.ORCID http://orcid.org/0000-0001-7818-678X
Maria Helena Galdino Figueiredo-CarvalhoMycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, FIOCRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil.
Rowena Alves CoelhoMycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, FIOCRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil.
Jean Carlos Almeida de OliveiraMycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, FIOCRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil.
Raissa Vieira MonteiroMycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, FIOCRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil.
Alessandra Leal da Silva ChavesClinical Pathology Laboratory, HCI, National Cancer Institute, Rio de Janeiro, Brazil.
Rodrigo Almeida-PaesMycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, FIOCRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-900, Brazil.
Fundação Oswaldo Cruz · BRHospital do Câncer III · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections caused by Rhodotorula spp. are increasing worldwide. This study identified, through the light of the new taxonomic advances on the subphylum Pucciniomycotina, 16 isolates from blood cultures and compared their antifungal susceptibility on microdilution and gradient diffusion methods. Internal transcriber spacer sequencing identified Rhodotorula mucilaginosa (n = 12), Rhodotorula toruloides (n = 2), Rhodotorula dairenensis (n = 1), and Cystobasidium minutum (n = 1). Amphotericin B was the most effective drug. A good essential agreement was observed on MIC values of amphotericin B and voriconazole determined by the two methods. Therefore, the gradient method is useful for susceptibility tests of R. mucilaginosa against these drugs.

Indexed as

Amphotericin BAntifungal AgentsBlood CultureBrazilDiffusionDNA, IntergenicHumansMicrobial Sensitivity TestsMycosesRhodotorulaVoriconazoleAmphotericin BAntifungal AgentsDNA, IntergenicVoriconazoleAntifungal susceptibilityBloodstream infectionsITS sequencingOpportunistic fungiRhodotorula

Identifiers

PMID31776863
PMCPMC7058769
OpenAlexW2989721978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.